Evidence of Mpox Virus Infection Among Persons Without Characteristic Lesions or Rash Presenting for First Dose of JYNNEOS Vaccine—District of Columbia, August 2022

著者: Yasmin P. Ogale, Nicolle Baird, Michael B. Townsend, Isha Berry, Isabel Griffin, Michelle Lee, Patrick Ashley, Trevor Rhodes, Tiffany Notigan, Nhien T. Wynn, C. Kling, Todd Smith, Lalita Priyamvada, William Carson, Terese Navarra, Patrick Dawson, Paul J. Weidle, Christina Willut, Anil T. Mangla, Panayampalli S. Satheshkumar, Christina L. Hutson, D.A. Jackson, Michelle A. Waltenburg, for the DC Mpox Response Project Team, Ausaf Ahmad, Jaia Armstrong, Marie E Brake, Paige Bunkley, Perri C. Callaway, Ayan K. Chakrabarti, Jennifer Folster, Catalina Forero, Bruce W. Furness, Claire Godino, L. Greenberg, Sarah Anne J. Guagliardo, Samadhan Jadhao, Teskisha Jordan, Emiko Kamitani, Barbara Chebet Keino, Erik Kopping, Joo Sang Lee, Leah Lopez, David Lowe, John Metz, Shanna Miko, Victoria Mrotz, Adi Noiman, James Partin, Melissa Brykailo Pearce, Kevin Pettus, Sergio Rodríguez, Susanna Sabin, Loredana Santo, Caroline A. Schrodt, Pankaj Sharma, Victoria Shelus, Dallas Shi, Olutomi Sodeke, Nora Springstubb, Christan Halverson Stager, Roxana Rodriguez Stewart, Xiaoling Tang, Moukaram Tertuliano, Logan Timm, Casey E. Vantucci, Gilberto Vaughan, Sarah Wondmeneh, Yong Yang, Eric Anthony, Marie Argyriou, Leslie Ayuk-Takor, Miriam F. Bryant, Angela Cherrix, David Coleman, Carole Cunningham, Ronit Dastidar, Olivia Dato, Azam Elnour, Sarah Gillani, Tracie Hartley, Dionnie Israel, Michelle Lee, Susan McCullam, Ie Meh, Tiffany Notigan, Saumya Rajamohan, Trevor Rhodes, Blanca Rosado, Julia Rowse, Brandon Shapiro, Kristen Smart, Michael Staff, Jaketia Taylor, Ricardo Webb, Rajanique White, Saria Widatalla, Shanice Wilson - Clinical Infectious Diseases 2023 被引用: 17

We assessed mpox virus prevalence in blood, pharyngeal, and rectal specimens among persons without characteristic rash presenting for JYNNEOS vaccine. Our data indicate that the utility of risk-based screening for mpox in persons without skin lesions or rash via pharyngeal swabs, rectal swabs, and/or blood is likely limited.